Matches in SemOpenAlex for { <https://semopenalex.org/work/W2164507773> ?p ?o ?g. }
- W2164507773 endingPage "1595" @default.
- W2164507773 startingPage "1589" @default.
- W2164507773 abstract "BackgroundThis study reports the results of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (dex) in patients with unresectable intrahepatic cholangiocarcinoma (ICC) or hepatocellular carcinoma (HCC) and investigates dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) assessment of tumor vascularity as a biomarker of outcome.Patients and methodsThirty-four unresectable patients (26 ICC and eight HCC) were treated with HAI FUDR/dex. Radiologic dynamic and pharmacokinetic parameters related to tumor perfusion were analyzed and correlated with response and survival.ResultsPartial responses were seen in 16 patients (47.1%); time to progression and response duration were 7.4 and 11.9 months, respectively. Median follow-up and median survival were 35 and 29.5 months, respectively; 2-year survival was 67%. DCE-MRI data showed that patients with pretreatment integrated area under the concentration curve of gadolinium contrast over 180 s (AUC 180) >34.2 mM·s had a longer median survival than those with AUC 180 <34 mM·s (35.1 versus 19.1 months, P = 0.002). Decreased volume transfer exchange between the vascular space and extracellular extravascular space (-ΔKtrans) and the corresponding rate constant (-Δkep) on the first post-treatment scan both predicted survival.ConclusionsIn patients with unresectable primary liver cancer, HAI therapy can be effective and safe. Pretreatment and early post-treatment changes in tumor perfusion characteristics may predict treatment outcome." @default.
- W2164507773 created "2016-06-24" @default.
- W2164507773 creator A5000913577 @default.
- W2164507773 creator A5005824918 @default.
- W2164507773 creator A5006244276 @default.
- W2164507773 creator A5021692050 @default.
- W2164507773 creator A5021772683 @default.
- W2164507773 creator A5042440032 @default.
- W2164507773 creator A5046143874 @default.
- W2164507773 creator A5051277222 @default.
- W2164507773 creator A5052004223 @default.
- W2164507773 creator A5058825770 @default.
- W2164507773 creator A5069644669 @default.
- W2164507773 creator A5082001484 @default.
- W2164507773 date "2009-09-01" @default.
- W2164507773 modified "2023-10-18" @default.
- W2164507773 title "Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival" @default.
- W2164507773 cites W1830311297 @default.
- W2164507773 cites W1977161163 @default.
- W2164507773 cites W1979423262 @default.
- W2164507773 cites W1985524610 @default.
- W2164507773 cites W1991701933 @default.
- W2164507773 cites W2001755384 @default.
- W2164507773 cites W2009828098 @default.
- W2164507773 cites W2018433986 @default.
- W2164507773 cites W2035808363 @default.
- W2164507773 cites W2040660791 @default.
- W2164507773 cites W2042098439 @default.
- W2164507773 cites W2050423483 @default.
- W2164507773 cites W2062497504 @default.
- W2164507773 cites W2076163094 @default.
- W2164507773 cites W2077126840 @default.
- W2164507773 cites W2078797029 @default.
- W2164507773 cites W2079040157 @default.
- W2164507773 cites W2096888043 @default.
- W2164507773 cites W2099708392 @default.
- W2164507773 cites W2099712907 @default.
- W2164507773 cites W2108610949 @default.
- W2164507773 cites W2117050193 @default.
- W2164507773 cites W2117889023 @default.
- W2164507773 cites W2118520585 @default.
- W2164507773 cites W2125763116 @default.
- W2164507773 cites W2139248078 @default.
- W2164507773 cites W2154009817 @default.
- W2164507773 cites W2156871508 @default.
- W2164507773 cites W2165760078 @default.
- W2164507773 cites W2170286781 @default.
- W2164507773 cites W2171229522 @default.
- W2164507773 cites W2314446169 @default.
- W2164507773 cites W2321119966 @default.
- W2164507773 cites W310150161 @default.
- W2164507773 doi "https://doi.org/10.1093/annonc/mdp029" @default.
- W2164507773 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2731015" @default.
- W2164507773 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19491285" @default.
- W2164507773 hasPublicationYear "2009" @default.
- W2164507773 type Work @default.
- W2164507773 sameAs 2164507773 @default.
- W2164507773 citedByCount "142" @default.
- W2164507773 countsByYear W21645077732012 @default.
- W2164507773 countsByYear W21645077732013 @default.
- W2164507773 countsByYear W21645077732014 @default.
- W2164507773 countsByYear W21645077732015 @default.
- W2164507773 countsByYear W21645077732016 @default.
- W2164507773 countsByYear W21645077732017 @default.
- W2164507773 countsByYear W21645077732018 @default.
- W2164507773 countsByYear W21645077732019 @default.
- W2164507773 countsByYear W21645077732020 @default.
- W2164507773 countsByYear W21645077732021 @default.
- W2164507773 countsByYear W21645077732022 @default.
- W2164507773 countsByYear W21645077732023 @default.
- W2164507773 crossrefType "journal-article" @default.
- W2164507773 hasAuthorship W2164507773A5000913577 @default.
- W2164507773 hasAuthorship W2164507773A5005824918 @default.
- W2164507773 hasAuthorship W2164507773A5006244276 @default.
- W2164507773 hasAuthorship W2164507773A5021692050 @default.
- W2164507773 hasAuthorship W2164507773A5021772683 @default.
- W2164507773 hasAuthorship W2164507773A5042440032 @default.
- W2164507773 hasAuthorship W2164507773A5046143874 @default.
- W2164507773 hasAuthorship W2164507773A5051277222 @default.
- W2164507773 hasAuthorship W2164507773A5052004223 @default.
- W2164507773 hasAuthorship W2164507773A5058825770 @default.
- W2164507773 hasAuthorship W2164507773A5069644669 @default.
- W2164507773 hasAuthorship W2164507773A5082001484 @default.
- W2164507773 hasBestOaLocation W21645077731 @default.
- W2164507773 hasConcept C126322002 @default.
- W2164507773 hasConcept C126838900 @default.
- W2164507773 hasConcept C126894567 @default.
- W2164507773 hasConcept C143409427 @default.
- W2164507773 hasConcept C146957229 @default.
- W2164507773 hasConcept C178596483 @default.
- W2164507773 hasConcept C185592680 @default.
- W2164507773 hasConcept C2776694085 @default.
- W2164507773 hasConcept C2778019345 @default.
- W2164507773 hasConcept C2779598120 @default.
- W2164507773 hasConcept C2780401358 @default.
- W2164507773 hasConcept C2780456651 @default.
- W2164507773 hasConcept C2781197716 @default.
- W2164507773 hasConcept C2989005 @default.